SLXN•benzinga•
Silexion Therapeutics To Present SIL-204 Data In KRAS-Driven Pancreatic Cancer At The 2025 ASCO Gastrointestinal Cancers Symposium
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2025 by benzinga